Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Title||Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43)|
|Recruitment||Active, not recruiting|
|Sponsors||Merck Sharp & Dohme Corp.|
|Age Groups:||senior | adult|
|Covered Countries||USA | ITA | FRA | ESP | DEU | CAN | BEL|